Next Issue
Volume 5, April
Previous Issue
Volume 4, February
 
 
Clinical and Translational Neuroscience is published by MDPI from Volume 5 Issue 2 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with SAGE.

Clin. Transl. Neurosci., Volume 4, Issue 2 (July 2020) – 9 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
263 KiB  
Conference Report
Abstract Book Swiss Neurological Society
by
Clin. Transl. Neurosci. 2020, 4(2), 20; https://doi.org/10.1177/2514183x20973127 - 17 Dec 2020
Viewed by 538
Abstract
Midregional-proatrial-natriuretic-peptide (MR-proANP) is a promising biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). [...] Full article
176 KiB  
Conference Report
Abstract Book: Joint Annual Congress of the Swiss Headache Society and the Swiss Pain Society
by
Clin. Transl. Neurosci. 2020, 4(2), 19; https://doi.org/10.1177/2514183x20973125 - 17 Dec 2020
Viewed by 496
Abstract
The percutaneous alcoholization of the gasserian ganglion through the foramen ovale for the treatment of trigeminal neuralgia is well known and has been applied extensively since the early 1980s. [...] Full article
499 KiB  
Systematic Review
Neuroplasticity in Children and Adolescents in Response to Treatment Intervention: A Systematic Review of the Literature
by Lisa L Weyandt, Christine M Clarkin, Emily Z Holding, Shannon E May, Marisa E Marraccini, Bergljot Gyda Gudmundsdottir, Emily Shepard and Lauren Thompson
Clin. Transl. Neurosci. 2020, 4(2), 21; https://doi.org/10.1177/2514183x20974231 - 8 Dec 2020
Cited by 19 | Viewed by 3790
Abstract
The purpose of the present study was to conduct a systematic review of the literature, adhering to PRISMA guidelines, regarding evidence of neuroplasticity in children and adolescents in response to cognitive or sensory-motor interventions. Twenty-eight studies employing seven different types of neuroimaging techniques [...] Read more.
The purpose of the present study was to conduct a systematic review of the literature, adhering to PRISMA guidelines, regarding evidence of neuroplasticity in children and adolescents in response to cognitive or sensory-motor interventions. Twenty-eight studies employing seven different types of neuroimaging techniques were included in the review. Findings revealed that significant variability existed across the 28 studies with regard to the clinical populations examined, type of interventions employed, neuroimaging methods, and the type of neuroimaging data included in the studies. Overall, results supported that experience-dependent interventions were associated with neuroplastic changes among children and adolescents in both neurotypical and clinical populations. However, it remains unclear whether these molecular neuroplastic changes, including the degree and direction of those differences, were the direct result of the intervention. Although the findings are encouraging, methodological limitations of the studies limit clinical utility of the results. Future studies are warranted that rigorously define the construct of neuroplasticity, establish consistent protocols across measurement techniques, and have adequate statistical power. Lastly, studies are needed to identify the functional and structural neuroplastic mechanisms that correspond with changes in cognition and behavior in child and adolescent samples. Full article
315 KiB  
Article
From First Symptoms to Diagnosis: Initial Clinical Presentation of Primary Brain Tumors
by B Alther, V Mylius, M Weller and AR Gantenbein
Clin. Transl. Neurosci. 2020, 4(2), 17; https://doi.org/10.1177/2514183x20968368 - 8 Dec 2020
Cited by 8 | Viewed by 832
Abstract
Background: Despite modern imaging methods, a long symptom-to-diagnosis interval can be observed in patients with primary brain tumors. Objective: The study evaluated the initial and subsequent clinical presentation of patients with brain tumors in the context of time to diagnosis, localization, histology, and [...] Read more.
Background: Despite modern imaging methods, a long symptom-to-diagnosis interval can be observed in patients with primary brain tumors. Objective: The study evaluated the initial and subsequent clinical presentation of patients with brain tumors in the context of time to diagnosis, localization, histology, and tumor grading. Methods: In this retrospective analysis of 85 consecutive patients with primary brain tumors, we assessed the presenting symptoms and signs. The analyses were based on entries from medical records at the Department of Neurology of Zurich University Hospital between 2005 and 2010. Results: A total of 54 men and 31 women with a mean age at diagnosis of 48 years were included. 60% of the patients present with a malignant tumor (World Health Organization grading III–IV), 24.7% with a benign tumor (I–II), and 15.3% were not classified. The interval between symptom onset and diagnosis varied from 1 day to 96 months (median: 39 days). High-grade tumors (III–IV) were diagnosed significantly earlier than low-grade tumors (II) after the first symptoms occurred (median: 26 vs. 138 days; z = −3.847, p < 0.001). Conclusions: Symptoms with a short symptom-to-diagnosis interval such as nausea/vomiting, seizures, as well as of personality change are assumed to contribute to a faster diagnosis in high-grade tumors. Visual disturbances and headaches, although occurring relatively seldom, did not contribute to a decrease in time to diagnosis and should therefore be considered for further diagnostic workup. Full article
581 KiB  
Article
Linear Oblique Craniectomy: A Novel Method of Minimally Invasive Subdural Grid Insertion
by Calvin W Howard, Nader S Aboelnazar, Noor Salem, Naweed Syed and Lian Willetts
Clin. Transl. Neurosci. 2020, 4(2), 18; https://doi.org/10.1177/2514183x20973085 - 26 Nov 2020
Viewed by 621
Abstract
Background: Many countries rely upon subdural grid electroencephalography in the planning of epilepsy surgeries. However, craniotomy for subdural grid implantation is known to result in a variety of complications and requires diligence from the surgical team. We describe a minimally invasive method of [...] Read more.
Background: Many countries rely upon subdural grid electroencephalography in the planning of epilepsy surgeries. However, craniotomy for subdural grid implantation is known to result in a variety of complications and requires diligence from the surgical team. We describe a minimally invasive method of subdural grid insertion, termed the linear oblique craniectomy, designed to mitigate complications and increase ease of subdural grid insertion. Objective: To demonstrate feasibility of minimally invasive subdural grid insertion utilizing skull anatomy. Methods: Three fresh frozen and embalmed human cadavers underwent surface landmarking and craniectomy to introduce a 4 × 5 cm2 subdural grid over the Sylvian fissure. Anteroposterior lens-shaped craniectomy measured 5 cm in length with 1 cm maximal width. The dura mater was longitudinally incised, and subdural grids were introduced over the Sylvian fissure. Results: The total area of the craniectomy created by the linear oblique approach consists of only approximately 20% of the total area removed by the traditional approach to access the Sylvian fissure for mesial temporal epilepsy monitoring/preoperative planning. The locations of the grids were evaluated by MRI and computed tomography scans postoperatively to ensure accurate alignment with the Sylvian fissure. Conclusion: In this cadaveric study, we demonstrate the linear oblique craniectomy procedure that provides an alternative approach to subdural grid implantation with significantly decreased invasiveness. This surgical approach has the potential of reducing complication rates of subdural grid insertion for surface monitoring of the brain activity and/or neuromachine interface analysis and is associated with significant reduction of surgical time. Full article
523 KiB  
Article
Postacute Administration of the GABAA α5 Antagonist S44819 Promotes Recovery of Peripheral Limb Fine Motor Skills after Permanent Distal Middle Cerebral Artery Occlusion in Rats
by Marta Pace, Matteo Falappa, Patricia Machado, Laura Facchin, Dirk M Hermann and Claudio L Bassetti
Clin. Transl. Neurosci. 2020, 4(2), 14; https://doi.org/10.1177/2514183x20948306 - 20 Nov 2020
Viewed by 592
Abstract
Background: Ischemic stroke causes hypoexcitability in the peri-infarct motor neocortex that stems from increased tonic γ-amino-butyric acid (GABA) activity in neurons. This hypoexcitability, while neuroprotective in the acute phase, may impair neuroplasticity and functional recovery in the subacute phase of stroke. The [...] Read more.
Background: Ischemic stroke causes hypoexcitability in the peri-infarct motor neocortex that stems from increased tonic γ-amino-butyric acid (GABA) activity in neurons. This hypoexcitability, while neuroprotective in the acute phase, may impair neuroplasticity and functional recovery in the subacute phase of stroke. The purpose of this study is to investigate the effect of delayed and prolonged administration of S44819, which is a potent and competitive selective antagonist of GABAA receptors, on the skilled reaching function in a rodent model of stroke. Methods: Male Sprague–Dawley rats (n = 15) were subjected to permanent middle cerebral artery occlusion. Starting 3 days after stroke, a vehicle or S44819 (3 or 10 mg/kg, BID) was delivered orally twice a day for 28 days. All animals were euthanized 2 weeks later after the washout period. A single pellet reaching task (SPR) was performed before (baseline value) and after the ischemic surgery at several time points (3, 10, 17, 24, 31, 38, and 45 days) to assess the motor deficit. Infarct volume and body changes were also evaluated. Results: S44819, administered at 10 but not 3 mg/kg, significantly improves SPR results over the 45 days after the ischemic surgery. No effect was observed in the infarct size and in the body weight over time between the groups investigated. Conclusion: S44819 at 10 mg/kg significantly enhances motor recovery on a skilled reaching task after sensory-motor cortex lesion. Additionally, our study, in light of the results of the RESTORE BRAIN (Randomized Efficacy and Safety Trial of Oral GABAA α5 antagonist S44819 after Recent ischemic Event) trial, may help clinicians to design clinical studies and stratify variables and patients adequately. Full article
183 KiB  
Editorial
Reflection on Career Choices in Clinical Neurosciences
by A Restellini and C Piguet
Clin. Transl. Neurosci. 2020, 4(2), 16; https://doi.org/10.1177/2514183x20968367 - 3 Nov 2020
Viewed by 425
Abstract
Medical faculties are responsible for high-level training, not only on clinical skills but also on scientific research and medical advances. There is an evident need to promote academic careers to ensure the continuity and improvement of top-notch health care. Even if Switzerland is [...] Read more.
Medical faculties are responsible for high-level training, not only on clinical skills but also on scientific research and medical advances. There is an evident need to promote academic careers to ensure the continuity and improvement of top-notch health care. Even if Switzerland is one of the countries with the highest medical density per inhabitant, the lack of interest for academic careers has increased, resulting in difficulties to form clinician-scientists and ensure succession. In this article, we reflect on the challenges and the potential solutions in the training of an academic career. Full article
175 KiB  
Book Review
Book Review: Neurology and Religion
by Jürg Kesselring
Clin. Transl. Neurosci. 2020, 4(2), 15; https://doi.org/10.1177/2514183x20957156 - 13 Oct 2020
Viewed by 461
Abstract
This very readable and erudite book on neurology and religion, edited and co-authored by well-known and very knowledgeable experts in theology and philosophy as well as in neuroscience and medicine. They take on the difficult task to try to explain religious experience and [...] Read more.
This very readable and erudite book on neurology and religion, edited and co-authored by well-known and very knowledgeable experts in theology and philosophy as well as in neuroscience and medicine. They take on the difficult task to try to explain religious experience and behaviour in neuroscientific terms to study correlations of neural phenomena with subjective experiences of spirituality and hypotheses to explain such phenomena. There probably is a neurological and evolutionary basis for subjective experiences traditionally categorized as spiritual or religious. Full article
440 KiB  
Article
Diagnosis of Epilepsy after First Seizure. Introducing the SWISS FIRST Study
by Baudouin Zongxin Jin, Pia De Stefano, Valentina Petroulia, Christian Rummel, Claus Kiefer, Mauricio Reyes, Kaspar Schindler, Pieter van Mierlo, Margitta Seeck and Roland Wiest
Clin. Transl. Neurosci. 2020, 4(2), 13; https://doi.org/10.1177/2514183x20939448 - 16 Jul 2020
Cited by 5 | Viewed by 628
Abstract
Diagnosis of epilepsy after a first unprovoked seizure is possible according to the guidelines by the International League Against Epilepsy, if the risk recurrence of a second unprovoked seizure is exceeding 60%. However, this cutoff constitutes only a proxy depending on the patients’ [...] Read more.
Diagnosis of epilepsy after a first unprovoked seizure is possible according to the guidelines by the International League Against Epilepsy, if the risk recurrence of a second unprovoked seizure is exceeding 60%. However, this cutoff constitutes only a proxy depending on the patients’ history, magnetic resonance imaging (MRI), and electroencephalography (EEG) findings but nevertheless also from the treating neurologists’ individual experience. In a Switzerland-wide observational study, we aim to recruit patients that were admitted to the emergency department with the referral diagnosis of a first and unprovoked seizure. We make use of optimized MRI protocols to identify potential structural epileptogenic lesions, introduce new imaging-based markers of epileptogenecity, and use most recent postprocessing methods as automatic morphometry, spike map analysis, and functional connectivity. With these diagnostic tools, we aim to segregate patients that present with epileptic seizures versus mimicks and non-epileptic seizures and stratify for every finding in MRI and EEG its predictive value for a second unprovoked seizure. These findings shall support neurologists to calculate and not only estimate the seizure recurrence rate in future. Full article
Previous Issue
Next Issue
Back to TopTop